Drag

Aurobindo Pharma Limited

Healthcare AUROPHARMA

1227.40INR
56.40 ( 4.82%)

Last update at

Day Range

1211.201247.30
LowHigh

52 Week Range

1006.22 1273.82
LowHigh

Fundamentals

  • Previous Close 1171.00
  • Market Cap 700504.80M
  • Volume2,346,654
  • P/E Ratio 20.47
  • EBITDA 65321.60M
  • Revenue TTM 325144.81M
  • Revenue Per Share TTM 559.82
  • Gross Profit TTM 187354.91M
  • Diluted EPS TTM 58.93

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Total Revenue
Net Income

Balance Sheet

Total Assets
Total Liabilities

Change in Cash

Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Income before tax 50662.90M 43799.90M 26125.00M 33727.40M 73435.90M
Net income 34858.80M 31729.70M 19275.00M 26481.50M 53348.40M
Total Revenue 317237.30M 290018.70M 246171.30M 233665.50M 245579.40M
Gross Profit 182398.70M 160161.80M 133238.70M 132262.70M 146554.70M
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Total assets 497849.70M 450715.10M 398899.90M 339217.20M 338539.90M
Intangible assets 36207.00M 34814.60M 33258.50M 31378.70M 26907.00M
Other current assets 26217.50M 32554.90M 18687.00M 15550.10M 14488.10M
Deferred long term liab - - - 1791.60M 1361.00M
Non current assets other - - - - -
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Change in Cash 21783.60M -10068.40M 2297.60M -11674.00M 25830.90M
Operating Cash 39246.20M 24345.20M 23867.50M 50164.80M 33289.20M
Free Cash Flow 19567.60M -11269.80M -3336.50M 23118.40M 14551.10M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change Price Market Cap (M) P/E Ratio
AUROPHARMA
Aurobindo Pharma Limited 		56.40 4.82% 1227.40 700504.80 20.47
SUNPHARMA
Sun Pharmaceutical Industries Limited 		74.80 4.59% 1702.70 4224508.76 40.32
DIVISLAB
Divi's Laboratories Limited 		260.50 4.38% 6213.00 1752225.28 70.47
TORNTPHARM
Torrent Pharmaceuticals Limited 		52.30 1.31% 4039.50 1362716.66 63.48
CIPLA
Cipla Limited 		9.90 0.75% 1321.50 1183505.97 21.74

Profile

Aurobindo Pharma Limited, a biopharmaceutical company, develops, manufactures, commercializes, and sells generic pharmaceuticals, active pharmaceutical ingredients (APIs), and injectables. The company offers formulation in form of oral solids, liquids, injectables, vaccines, and metered dose inhalers; and APIs, biosimilars, and peptides targeting therapeutic areas, such as central nervous system, cardiovascular, respiratory, antibiotics, anti-retroviral, anti-diabetics, gastroenterology, oncology, and dermatology. It also provides antiretroviral drugs for the people and children living with HIV; and API space for sterile and non-sterile penicillin's, cephalosporins, penems, and non-beta lactams. The company has operations in India, the United States, Europe, Puerto Rico, and internationally. The company was incorporated in 1986 and is headquartered in Hyderabad, India.

Aurobindo Pharma Limited

Galaxy, Plot No. 1, Hyderabad, India, 500032

Key Executives

Name Title Year Born
Mr. Kambam Nithyananda Reddy Vice Chairman & MD 1958
Dr. Meenakshi Sunderam Sivakumaran Whole-Time Director 1943
Mr. Mettu Madan Mohan Reddy Whole-Time Director 1960
Mr. Penaka Sarath Chandra Reddy Whole-Time Director 1985
Mr. Santhanam Subramanian Chief Financial Officer 1961
Mr. Sanjeev Indravadan Dani COO & Head of Formulations 1960
Dr. S. Vijaya Kumar Pres of Technical 1966
Mr. Arvind Bothra Head of Investor Relations & Corp. Communications NA
Mr. B. Adi Reddy Compliance Officer & Company Sec. NA
Mr. G. P. Prasad Sr. VP of Global Fin. & Operations NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data ("EODHD") on an 'as is' basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.